Office of Infectious Disease Services
Clinical Laboratory Reporting
When should I report?
Most disease reports should be submitted within five (5) working days of obtaining a positive test result or the described test result. However, some reports must be made within 24 hours of a positive test result or even immediately after receiving one specimen to be tested for an agent.
Please see the downloadable list for complete reporting specifications and timelines.
How should I report?
To report, please complete the Laboratory Reporting Form.
Electronic Laboratory Reporting (ELR) is the automated, secure electronic transmission of laboratory reports identified as reportable conditions from laboratories to public health. If your laboratory is interested in setting up ELR, please visit the ELR page for more information.
Who should receive the report?
Reports should be mailed or faxed to:
- LS Coordinator
Arizona Department of Health Services
Infectious Disease Epidemiology
150 N. 18th Avenue, Suite 140
Phoenix, AZ 85007
(602) 364-3199 Fax
What information is required?
The report may be written or electronic or a faxed printout of the laboratory results. The laboratory report shall include:
- Name, and if available, address and telephone number of the patient
- Birth date of the patient
- Reference number
- Specimen type
- Date of collection
- Type of test
- Test results
- Ordering healthcare provider's name and telephone number.
Which pathogens and laboratory tests are reportable?
See the downloadable reportable disease list for complete specifications and timelines.
For agents marked with an asterisk (*) on the list below, isolates must be sent to the Arizona State Public Health Laboratory, 250 N. 17th Ave., Phoenix, AZ 85007, (602) 542-1190.
For agents marked with a plus (+) on the list below, a specimen must be submitted to the Arizona State Public Health Laboratory within 24 hours of obtaining the positive test result.
- Bacillus anthracis *
- Bordetella pertussis *
- Brucella spp. *
- Burkholderia mallei and B. pseudomallei *
- Campylobacter spp.
- CD4-T-lymphocyte count of <14%
- Chlamydia trachomatis
- Clostridium botulinum toxin (botulism) *
- Coccidioides: culture or serologies
- Coxiella burnetii
- Cryptosporidium spp.
- Cyclospora spp.
- Dengue virus
- Emerging or exotic disease agent
- Entamoeba histolytica
- Escherichia coli O157:H7 *
- Escherichia coli, Shiga-toxin producing *
- Francisella tularensis *
- Haemophilus influenzae: isolated from a normally sterile site *
- Hepatitis A virus (anti-HAV IgM serologies)
- Hepatitis B virus (anti-Hepatitis B core IgM, Hepatitis B surface or envelope antigen serologies, or detection of viral nucleic acid)
- Hepatitis C virus
- Hepatitis D virus
- Hepatitis E virus (anti-HEV-IgM serologies) +
- Human Immunodeficiency Virus (HIV)
- Human Immunodeficiency Virus (HIV)—any test result from an infant
- Influenza virus
- Legionella spp. (culture or DFA) *
- Listeria spp.: isolated from a normally sterile site *
- Measles virus and anti-measles-IgM serologies +
- Methicillin-resistant Staphylococcus aureus, isolated from a normally sterile site
- Mumps virus and anti-mumps-IgM serologies +
- Mycobacterium tuberculosis complex and its drug susceptibility pattern *
- Neisseria gonorrhoeae
- Neisseria meningitidis, isolated from a normally sterile site *
- Plasmodium spp.
- Respiratory syncytial virus
- Rubella virus and anti-rubella-IgM serologies +
- Salmonella spp. *
- SARS-associated corona virus
- Shigella spp. *
- Streptococcus Group A: isolated from a normally sterile site
- Streptococcus Group B: isolated from a normally sterile site in an infant
- Streptococcus pneumoniae and its drug sensitivity pattern: isolated from a normally sterile site *
- Treponema pallidum (syphilis)
- Trypanosoma cruzi (Chagas disease)
- Vancomycin-resistant or Vancomycin-intermediate Staphylococcus aureus *
- Vancomycin resistant Staphylococcus epidermidis *
- Variola virus (smallpox)
- Vibrio spp. *
- Viral hemorrhagic fever agent
- West Nile virus
- Yersinia spp. *